Scinovex
reviewTop 1% cited

Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease

Nature Reviews Drug Discovery · 2006 · Vol. 5(2) · pp. 123–132
Advanced biosensing and bioanalysis techniquesOcular Diseases and Behçet’s SyndromeRetinal Development and DisordersPegaptanibAptamerMacular degenerationVascular endothelial growth factorChoroidal neovascularizationMedicinePharmacologyNeovascularizationBevacizumabVEGF receptors

MeSH terms

AnimalsClinical Trials as TopicDiabetic RetinopathyEyeEye DiseasesHumansNeovascularization, PathologicDrug Delivery SystemsAngiogenesis InhibitorsVascular Endothelial Growth Factor AAptamers, Nucleotide
Citations
1,556
FWCI
26.20
field-weighted impact
References
101
Percentile
100%
vs. same field & year
Citations per year
Cited by
Aptamers as targeted therapeutics: current potential and challenges
Nature Reviews Drug Discovery · 2016 · 2,081 citations
Advances in oligonucleotide drug delivery
Nature Reviews Drug Discovery · 2020 · 1,897 citations
Aptamers: molecular tools for analytical applications
Analytical and Bioanalytical Chemistry · 2007 · 579 citations
Aptamers as therapeutics
Nature Reviews Drug Discovery · 2010 · 2,224 citations
The Pharmacology of PEGylation: Balancing PD with PK to Generate Novel Therapeutics
Journal of Pharmaceutical Sciences · 2008 · 468 citations
Methods developed for SELEX
Analytical and Bioanalytical Chemistry · 2006 · 385 citations
RNA-based therapeutics: an overview and prospectus
Cell Death and Disease · 2022 · 566 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.